Future Prospects for the Use of Nanomaterials in the Prevention, Diagnosis and Treatment of the Emerging COVID-19 Virus

Humanity looks forward to the vaccine that combats the emerging corona virus (COVID-19), and companies producing medical equipment are racing to produce materials that achieve protection against that new corona virus, which first appeared in Wuhan, China, on December 31, 2019. Scientific efforts are now focused on stemming the spread of the virus and reducing the risk of an increased threat from the COVID-19 virus through the use of sterilizers and social separation. But humankind needs other elements to stop the spread of this disease, so companies and research centers are racing to provide products that help fight the COVID-19 virus. This paper aims to shed light on the various nanotechnology products used to combat COVID-19 and their effectiveness in combating this pandemic, by retraining research aimed at producing nanomaterials that contribute to combating the virus. COVID-19. This paper is a narrative study and review conducted through research on the sites of companies producing medical materials based on nanotechnology and the inventory and inventory of nanomaterials used in the prevention, diagnosis and treatment of Corona virus COVID-19. SK COVID-19 The paper outlines the types of medical materials and equipment based on nanomaterials that are used to prevent COVID-19, such as masks, gloves, and disinfectants. The paper also demonstrated the contribution of nanotechnology to expediting the early diagnosis process and increasing the accuracy of diagnosis, using silica-coated nanoparticles that will enable us to perform 40,000 tests per day. The study also showed the future nanotechnology-based vaccines, which are seven in the clinical testing phase that are expected to combat the COVID-19 virus. This research shows that many nanotechnology products are used in the prevention, diagnosis and treatment of coronavirus, and the results showed that the nanomaterials used have shown high effectiveness in combating the COVID-19 virus.